RONALD HUNT - 22 Jun 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director, 10%+ Owner
Signature
/s/ Ronald Hunt by Frank J. Lanza, Attorney-in-Fact
Issuer symbol
HARP
Transactions as of
22 Jun 2023
Transactions value $
$0
Form type
4
Filing time
23 Jun 2023, 16:34:23 UTC
Previous filing
19 May 2023
Next filing
03 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +23,000 $0 23,000 22 Jun 2023 Common Stock 23,000 $0.6657 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on June 21, 2024, subject to the continuous service of the Reporting Person with the Issuer on such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney